BLEPHARITIS TREATMENT MARKET ANALYSIS

Regional Analysis

Blepharitis Treatment Market Regional Analysis:-

North America blepharitis treatment market is expected to hold dominant position due to increasing geriatric population, launch of new products, and increasing number of ophthalmic patients in the region. According to a survey conducted in the U.S. Population Reference Bureau, in 2016, the aging population in the U.S. increased by 24% as compared to 15% in 2014. Europe is expected to witness rapid growth due increasing product launch in the region. For instance, in 2017, Scope Ophthalmic launched Moist Heat Mask, a device that helps in the treatment of blepharitis by loosening the oil present in Meibomian glands and allowing it to flow more freely. It helps to soften eye lash debris, prevent the evaporation of natural tear film, restores moisture to the eye and also the surrounding area, as well as improves tear film lipid quality. In 2015, MiBo Medical Group, a U.S.-based company, launched MibO Thermoflo. This device helps in the treatment of blepharitis and dry eyes and is required to be gently massaged on the margins of the eyelids for a minimum of 12 minutes. In 2015, MiBo Medical Group launched Lid Pro, a device that is used for the treatment of anterior blepharitis. The market in Asia Pacific is expected to witness significant growth due to increasing prevalence of blepharitis. According to a study conducted by Journal of Clinical and Experimental Ophthalmology, in 2016, signs and symptoms of blepharitis increased by 32% among the geriatric population as compared to 2014.